This paper presents a multi-output converter using an asymmetrical PWM half bridge flyback topology employing a parallel-series connected transformer. Compared to conventional multi-output topologies, the proposed converter operates using a single output controller without the need for additional control loops and devices. In order to solve the cross regulation problem, the output stages of the proposed converter are stacked in series. In addition, the voltage regulation of the proposed multi-output converter is improved through the analysis of its resonant characteristics under load variations and minimizing the secondary conduction loss. The proposed multi-output converter shows excellent performance in terms of its output regulation from noload to full-load condition and good cross regulation under high output currents. The design methodology and performance of the proposed converter have been verified through experimentation employing a 110W (3.3V/16A, 5V/12A) prototype converter.
Optimal sizing of stationary energy storage systems (ESS) is required to reduce the peak load and increase the profit of fast charging stations. Sequential sizing of battery and converter or fixed-size converters are considered in most of the existing studies. However, sequential sizing or fixed-converter sizes may result in under or oversizing of ESS and thus fail to achieve the set targets, such as peak shaving and cost reduction. In order to address these issues, simultaneous sizing of battery and converter is proposed in this study. The proposed method has the ability to avoid the under or oversizing of ESS by considering the converter capacity and battery size as two independence decision variables. A mathematical problem is formulated by considering the stochastic return time of electrical vehicles (EVs), worst-case state of charge at return time, number of registered EVs, charging level of EVs, and other related parameters. The annualized cost of ESS is computed by considering the lifetime of ESS equipment and annual interest rates. The performance of the proposed method is compared with the existing sizing methods for ESS in fast-charging stations. In addition, sensitivity analysis is carried out to analyze the impact of different parameters on the size of the battery and the converter. Simulation results have proved that the proposed method is outperforming the existing sizing methods in terms of the total annual cost of the charging station and the amount of power buying during peak load intervals.
ObjectiveTo analyze the spectrum of prenatally diagnosed congenital heart disease in a Korean population with 22q11.2 deletion syndrome, and to provide guidelines for screening 22q11.2 deletion prenatally.MethodsThis retrospective study evaluated 1,137 consecutive fetuses that had prenatal genetic testing for 22q11.2 deletion because of suspected congenital heart disease between September 2002 and December 2012, at Asan Medical Center, Seoul, Korea.ResultsMain cardiovascular diseases in the 53 fetuses with confirmed 22q11.2 deletions were tetralogy of Fallot (n = 24, 45%), interrupted aortic arch (n = 10, 19%), ventricular septal defect (n = 5, 9%), double outlet right ventricle (n = 4, 8%), and coarctation of the aorta (n = 4, 8%). Other cardiac defects were rarely associated with 22q11.2 deletion. One fetus had persistent truncus arteriosus, one had aortic stenosis, and one had hypoplastic right heart syndrome. Two fetuses had normal intracardiac anatomy with an isolated right aortic arch, and one had an isolated bilateral superior vena cava.ConclusionA variety of congenital heart diseases were seen during the prenatal period. Conotruncal cardiac defects except transposition of great arteries were strongly associated with 22q11.2 deletion. When such anomalies are diagnosed by fetal echocardiography, genetic testing for 22q11.2 deletion should be offered. Even if less frequent deletion-related cardiac defects are detected, other related anomalies, such as thymic hypoplasia or aplasia, should be evaluated to rule out a 22q11.2 deletion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.